1 Guidance

1 Guidance

1.1 Current evidence on the safety and efficacy of photodynamic therapy (PDT) for brain tumours is limited in both quality and quantity. Therefore, this procedure should only be used in the context of randomised controlled trials with well-defined inclusion criteria (specifying the tumour type for inclusion in the trial) and treatment protocols, and with collection of both survival and quality of life outcomes.

  • National Institute for Health and Care Excellence (NICE)